$2.76
Value $43.5B
AmbevvsProcter & Gamble
ABEV and PG stock compared: price, dividend, valuation and results, from SEC filings.
+1.10%
$169.80
Value $395B
Ambev (ABEV) has a market value of $43.5B and Procter & Gamble (PG) $395B. Over the last year, with dividends, ABEV moved +9.9% and PG +18.0%. The P/E is 15.4 for ABEV and 25.1 for PG. Dividend yield: ABEV none, PG 2.55%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
ABEV$43.5B
PG$395B
PG is 9.1 times ABEV
Revenue, 12 months
ABEV$16.1B
PG$87.9B
PG is 5.5 times ABEV
Net income, 12 months
ABEV$2.8B
PG$16.0B
PG is 5.7 times ABEV
Operating margin
ABEV26.4%
PG22.6%
3.8 points apart
ROIC
ABEV20.0%
PG17.3%
2.7 points apart
P/E
ABEV15.4
PG25.1
PG is 1.6 times ABEV
Dividend yield
ABEV0.0%
PG2.6%
2.6 points apart
5-year return
ABEV+11.1%
PG+31.8%
20.7 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
ABEV+11.1%
PG+31.8%
| Period | ABEVWith dividends | PGWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +9.9%Price +9.1% | +18.0%Price +14.7% |
| 3 years since November 13, 2023 | +16.2%+5.1% a yearPrice +0.7% | +20.5%+6.4% a yearPrice +11.4% |
| 5 years since November 12, 2021 | +11.1%+2.1% a yearPrice -12.1% | +31.8%+5.7% a yearPrice +15.9% |
| 10 years since November 15, 2016 | -23.0%-2.6% a yearPrice -46.5% | +166.5%+10.3% a yearPrice +103.1% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
ABEVAmbevPGProcter & Gamble
Valuation
ABEVPG| Price | $2.76 | $169.80 |
|---|---|---|
| Market value | $43.5B | $395B |
| Enterprise value (EV) | $40.7B | $418B |
| P/E | 15.4 | 25.1 |
| P/E, 5-year median | 14.8 | 24.8 |
| P/B | 2.7 | 7.2 |
| EV/EBIT | 9.6 | 21.1 |
| Free cash flow yield | 8.3% | 3.9% |
Results and growth
ABEVPG| Revenue, 12 months | $16.1B | $87.9B |
|---|---|---|
| Net income, 12 months | $2.8B | $16.0B |
| Free cash flow, 12 months | $3.6B | $15.3B |
| Earnings per share, 12 months | $0.18 | $6.64 |
| Revenue growth, year on year | -1.4% | 3.3% |
| Revenue growth a year, past | +8.6%over 5 years | +2.7%over 5 years |
| EPS growth a year, past | +6.6%over 5 years | +3.8%over 5 years |
Margins and returns on capital
ABEVPG| Gross margin | 51.4% | 49.8% |
|---|---|---|
| Operating margin | 26.4% | 22.6% |
| Net margin | 17.6% | 18.2% |
| ROIC | 20.0% | 17.3% |
| ROE | 17.5% | 29.5% |
Balance sheet
ABEVPG| Cash | $3.4B | $15.4B |
|---|---|---|
| Total debt | $618M | $38.9B |
| Net debt / EBITDA | -0.5 | 1.0 |
| Interest cover | – | 22.0× |
Dividends and buybacks
ABEVPG| Dividend yield | – | 2.6% |
|---|---|---|
| Dividend per share, 12 months | – | $4.32 |
| Dividend growth a year, past | – | +5.6%over 5 years |
| Buyback yield | – | 1.3% |
| Shareholder yield | – | 3.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Ambev or Procter & Gamble?
By market value, Procter & Gamble ($395B) is about 9.1 times Ambev ($43.5B), at today's prices.
How did ABEV and PG stock do over the last 10 years?
Since November 15, 2016, ABEV's price moved -46.5% and PG's +103.1%. With dividends: ABEV -23.0% (-2.6% a year), PG +166.5% (+10.3% a year). Past returns do not predict future ones.
Which pays the higher dividend, ABEV or PG?
The dividend yield at today's price is none for Ambev and 2.55% for Procter & Gamble. Over the last twelve months they paid – and $4.32 per share.
What is the P/E of ABEV and PG?
At today's price, the P/E is 15.4 for ABEV and 25.1 for PG. The median of the last five years was 14.8 and 24.8, which shows where each stands against its own past.
Which has the higher profit margins, Ambev or Procter & Gamble?
Over the last twelve months, the net margin was 17.6% for Ambev and 18.2% for Procter & Gamble, and the operating margin 26.4% and 22.6%. Revenue was $16.1B and $87.9B.
Which is the better investment, Ambev or Procter & Gamble?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.